3Ferrari E,Baudouy M,Cerboni P. Clinical epidemiology of venous thrombolitic disease.Results of a french multicentre registry[J].European Heart Journal,1997.685.doi:10.1093/oxfordjournals.eurheartj.a015316.
4Guohao Dai MS,a Olga Tsukurov,Roslyn Orkia. An in vitro cell culture system to study the influence of external pneumatic compression on endothelial function[J].Jouinal of Vascular Surgery,2000,(05):977-987.
5Comero ta AJ,Chouhan V,Harada RN. The fibrinolytic effects of interm ittent pneumatic compression:Mechanism of enhanced fibrinolysis[J].Annals of Surgery,1997,(03):3066.
6J acobs DG,P io trow sk i JJ,Hoppensteadt DA. Hemodynamic and fibrinolytic consequences of intermittent pneumatic compression:P reliminary results[J].Journal of Trauma,1996,(05):710.doi:10.1097/00005373-199605000-00005.
7Kakkos SK,Nicolaides AN,Griffin M. Comparison of two intermittent pneumatic compression systems.A hemodynamic study[J].International Angiology,2005,(04):330-335.
8Westrich GH,Bottner F,Windsor RE. VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty[J].Journal of Arthroplasty,2006,(6 Suppl 2):139-143.
